Literature DB >> 11224544

Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons.

C A Paladini1, C D Fiorillo, H Morikawa, J T Williams.   

Abstract

Amphetamine is a highly addictive psychostimulant that promotes the release of the catecholamines dopamine and norepinephrine. Amphetamine-induced release of dopamine in the midbrain inhibits the activity of dopamine neurons through activation of D2 dopamine autoreceptors. Here we show that amphetamine may also excite dopamine neurons through modulation of glutamate neurotransmission. Amphetamine potently inhibits metabotropic glutamate receptor (mGluR)-mediated IPSPs in dopamine neurons, but has no effect on ionotropic glutamate receptor-mediated EPSCs. Amphetamine desensitizes the mGluR-mediated hyperpolarization through release of dopamine, activation of postsynaptic alpha1 adrenergic receptors, and suppression of InsP3-induced calcium release from internal stores. By selectively suppressing the inhibitory component of glutamate-mediated transmission, amphetamine may promote burst firing of dopamine neurons. Through this mechanism, amphetamine may enhance phasic release of dopamine, which is important in the neural processing of reward.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11224544     DOI: 10.1038/85124

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  52 in total

1.  Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.

Authors:  Yolanda Mateo; Evgeny A Budygin; Carrie E John; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

2.  An increase in AMPA and a decrease in SK conductance increase burst firing by different mechanisms in a model of a dopamine neuron in vivo.

Authors:  C C Canavier; R S Landry
Journal:  J Neurophysiol       Date:  2006-08-02       Impact factor: 2.714

3.  CRF facilitates calcium release from intracellular stores in midbrain dopamine neurons.

Authors:  Arthur C Riegel; John T Williams
Journal:  Neuron       Date:  2008-02-28       Impact factor: 17.173

4.  Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Authors:  Amy J Ramsey; Aki Laakso; Michel Cyr; Tatyana D Sotnikova; Ali Salahpour; Ivan O Medvedev; Linda A Dykstra; Raul R Gainetdinov; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

5.  Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.

Authors:  Gunasingh Jeyaraj Masilamoni; Olivia Groover; Yoland Smith
Journal:  Neurobiol Dis       Date:  2016-12-30       Impact factor: 5.996

6.  Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons.

Authors:  Bruno A Benítez; Helen M Belálcazar; Agustín Anastasía; Daniel T Mamah; Charles F Zorumski; Daniel H Mascó; Daniel G Herrera; Gabriel A de Erausquin
Journal:  Neuropharmacology       Date:  2010-10-31       Impact factor: 5.250

7.  Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress.

Authors:  Zoé A McElligott; Jason R Klug; William P Nobis; Sachin Patel; Brad A Grueter; Thomas L Kash; Danny G Winder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

8.  Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers.

Authors:  Carlos A Mejías-Aponte; Candice Drouin; Gary Aston-Jones
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

9.  An intrinsic neuronal oscillator underlies dopaminergic neuron bursting.

Authors:  Christopher A Deister; Mark A Teagarden; Charles J Wilson; Carlos A Paladini
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

Review 10.  Illicit dopamine transients: reconciling actions of abused drugs.

Authors:  Dan P Covey; Mitchell F Roitman; Paul A Garris
Journal:  Trends Neurosci       Date:  2014-03-20       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.